Humanized anti-GPC3 antibodies resolve immunogenicity risks in CAR-T therapy by targeting hepatocellular carcinoma without triggering allergic reactions.
DEAE-Dextran preconditioning resolves the contradiction between high angiogenic potential and low transduction efficiency in vascular cell therapy.
Centrifugal separation of urine exosomes enables detection of HIV-associated proteins, resolving the trade-off between diagnostic accuracy and patient comfort.
Engineered T cells express anti-LIV1 chimeric antigen receptors to bind and lyse LIV1-positive cancer cells.
A targeting endonuclease creates a double-stranded break to enable homology-directed repair for in-frame tag integration.
Segmented targeting reduces background noise while improving imaging specificity and treatment coverage.
Fusing integral membrane proteins with vaccinia F13L displays them on extracellular enveloped virions, resolving bacterial folding failures.
Engineered E4ORF1+ endothelial cells generate blood-brain barrier-like tissues with high trans-endothelial electrical resistance.
Induced pluripotent stem cells generated from adult tissue samples enable versatile regenerative medicine applications.
A genetic construct uses a radiation-responsive promoter to drive localized therapeutic gene expression within targeted tissues.